Literature DB >> 1396892

Effect of dexamethasone on blood pressure--relationship to postnatal age.

E F Emery1, A Greenough.   

Abstract

The relationship of the change in blood pressure levels of very preterm infants treated with dexamethasone to postnatal age was investigated. Sixteen infants, median gestational age 26 weeks (range 23-33) (early treatment group), and 15 infants, median gestational age 26 weeks (range 24-32) (late treatment group) were recruited. Dexamethasone was administered at a median postnatal age of 17 days (range 3-26) and 50 days (range 29-112), respectively. The systolic blood pressure at the start of treatment and the maximum systolic blood pressure achieved during therapy were both significantly lower (P less than 0.01) in the early rather than the late treatment group. The change in blood pressure, however, that is, from the pre-treatment level to the maximum systolic blood pressure achieved during therapy, was similar in the two groups (median 38 mmHg, range 23-59 early treatment group and median 34 mmHg, range 16-66 late treatment group). We conclude that, even in the first 4 weeks of life, dexamethasone can cause a marked elevation of systolic blood pressure. As a consequence, regardless of the postnatal age at which dexamethasone is administered, blood pressure levels must be measured regularly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396892     DOI: 10.1007/bf02113259

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Blood pressure in very low birth weight infants in the first 70 days of life.

Authors:  K L Tan
Journal:  J Pediatr       Date:  1988-02       Impact factor: 4.406

3.  Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

Authors:  T F Yeh; J A Torre; A Rastogi; M A Anyebuno; R S Pildes
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

Review 4.  The hypertensive neonate.

Authors:  R D Adelman
Journal:  Clin Perinatol       Date:  1988-09       Impact factor: 3.430

5.  Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.

Authors:  G B Avery; A B Fletcher; M Kaplan; D S Brudno
Journal:  Pediatrics       Date:  1985-01       Impact factor: 7.124

6.  Systolic blood pressure in a population of infants in the first year of life: the Brompton study.

Authors:  M de Swiet; P Fayers; E A Shinebourne
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

7.  Hypertensive retinopathy in the newborn infant.

Authors:  M E Skalina; W L Annable; R M Kliegman; A A Fanaroff
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

8.  Systemic hypertension in infants with bronchopulmonary dysplasia.

Authors:  S H Abman; B A Warady; G M Lum; B L Koops
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

9.  Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.

Authors:  K L Harkavy; J W Scanlon; P K Chowdhry; L J Grylack
Journal:  J Pediatr       Date:  1989-12       Impact factor: 4.406

10.  A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

Authors:  J J Cummings; D B D'Eugenio; S J Gross
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245

  10 in total
  3 in total

Review 1.  Corticosteroids for treating hypotension in preterm infants.

Authors:  Hafis Ibrahim; Ian P Sinha; Nimish V Subhedar
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Effect of chronic lung disease on blood pressure levels at follow up.

Authors:  A Greenough; E F Emery
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

3.  Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease.

Authors:  K Smets; P Vanhaesebrouck
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.